2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
June 7th, 2025
Version: 2
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
cancer biology
biorxiv

Targeting Neutrophil Extracellular Traps to inhibit Colon Cancer Tumor Necrosis and Metastasis

Gazzara, E.Open in Google Scholar•Adrover, J. M.Open in Google Scholar•Lui, A.Open in Google Scholar•Han, S.Open in Google Scholar•Aminzada, Z.Open in Google Scholar•Bhandari, N.Open in Google Scholar•Sivetz, N.Open in Google Scholar•Shirue, V. S.Open in Google Scholar•Shergill, B. S.Open in Google Scholar•Curtis, M. B.Open in Google Scholaret al.

Necrosis, conventionally thought of as a passive consequence of aggressive tumor growth, is associated with poor prognosis in colorectal cancer (CRC). We recently discovered that necrosis can be caused by neutrophil extracellular trap (NET) aggregates driving vascular occlusion within the tumor vasculature in models of breast cancer. Here, we evaluated the role of NETs in inducing necrosis and metastasis in CRC. We found that the numbers of neutrophils primed to form NETs were elevated in the circulation of patients with CRC as compared to controls. CD177Low neutrophils were also elevated, and they showed reduced extravasation capacity with intact ability to form NETs. The extent of necrosis correlated with metastasis (stage IV disease), independent of tumor size, in our human cohort. In both human and murine CRC tumors, necrotic regions were characterized by neutrophil infiltration and NET accumulation, and NET aggregates were observed in the vasculature next to the necrotic regions. Single cell RNA sequencing and spatial transcriptomic analysis of human CRC and liver metastases revealed that necrotic tumors activate pathways associated with increased metastatic potential, including epithelial-to-mesenchymal-transition. Using a mouse model of DNA mismatch repair proficient CRC, we found neutrophil infiltration and NETs increased with tumor progression. Genetic or pharmacological inhibition of NET formation decreased necrosis and metastasis, and importantly enhanced chemotherapy efficacy. Altogether, our findings show that NET formation in human CRC is a key feature of tumor necrosis and it is associated with metastasis, and further suggest that preventing NET formation may offer clinical benefits to CRC patients.

Similar Papers

biorxiv
Sat Jun 07 2025
Improving Differential Expression and Survival Analyses with Sample Specific Compartment Deconvolution.
Motivation: Studies on bulk RNA-seq of tumor biopsies can yield incorrect results because varying proportions of non-tumor tissues in the samples obscure the true signal and impact the accuracy of survival and differential expression analyses. Single-cell sequencing avoids these problems, but is still too expensive in clinical settings. Other deconvolution algorithms extract tissue-specific gene e...
Yurovsky, A.
•
Moffitt, R. A.
biorxiv
Sat Jun 07 2025
Tumor-Educated-Platelets interact with Breast Cancer-Stem-Cells via P-selectin- PSGL1 and ensure stemness and metastasis through WNT-β-Catenin-VEGF-VEGFR2 intra-cellular signaling: Therapeutic modulation by aspirin
Background: Protagonistic role of platelets promote capillary infiltration of tumors for distant metastasis along with immunosurveillance. Despite existing reports highlighting role of platelets in tumorigenesis, its impact on breast cancer stem cells (BCSCs) remain underexplored. Our first ever report on murine and human system, accentuate that, tumor educated platelets (TEPs) of luminal A and TN...
Guha, A.
•
Sultana, J.
•
Bhuniya, A.
•
Chakravarti, M.
...•
Banerjee, S.
biorxiv
Sat Jun 07 2025
TATA box-based analysis reveals activation of growth programs in bladder cancer cells despite ferroptosis activation
A poorly studied mechanism suggests that growth is characterized by the expression of TATA-less genes under favorable conditions, while stress induces TATA-containing genes involved in stress responses. The role of this mechanism in cancer remains unclear. This study analyzes the presence of TATA boxes in gene expression data from bladder cancer (BC) cells undergoing ferroptosis (siUSP52 cells), a...
Fernandez, M. A.
•
Armisen, R.
•
Fernandez, M. I.
biorxiv
Sat Jun 07 2025
Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer Pathways
Persistent infection with human papillomavirus (HPV) is the primary cause of cervical cancer worldwide. Notably, women co-infected with HPV and human immunodeficiency virus type 1 (HIV-1) have a six-fold higher lifetime risk of developing cervical cancer compared to those without HIV, even when adhering to antiretroviral therapy (ART) and achieving T-cell reconstitution. While chronic HIV-1 infect...
Olwal, C. O.
•
Rathore, U.
•
Makanani, S.
•
Kaushal, P.
...•
Bouhaddou, M.
biorxiv
Sat Jun 07 2025
Breast Cancer Clustering Integrating Complete Gene Expression Profiles and Genetic Ancestry
Breast cancer (BC) remains the leading cause of cancer-related mortality among women globally. Precise subtyping of BC is critical for optimizing treatment strategies. This study explored the capacity of bulk RNA-seq data to improve breast cancer characterization by analysis of complete expression profiles. We analyzed RNA-seq 274 tumor samples and six healthy tissue samples from diverse geographi...
Stepanian, J.
•
Mejia-Garcia, A.
•
Orozco, C.
•
Duitama, J.
biorxiv
Sat Jun 07 2025
Optimising Chemotherapy for Locally Advanced High-Grade Serous Ovarian Cancer via Delay-Differential Equations
Ovarian cancer is the deadliest gynaecological cancer and the fourth leading cause of cancer deaths in women. High-grade serous ovarian cancer (HGSOC) accounts for 75% of cases, and chemotherapy resistance and relapse occur in 85% of patients, leading to a 5-year survival of 45%. Currently, the literature lacks comprehensive immunobiological models of HGSOC, and developing such models could provid...
Koprinski, C.
•
Hawi, G.
•
Kim, P. S.
biorxiv
Sat Jun 07 2025
Dietary lipids, not ketone body metabolites, influence intestinal tumorigenesis in a ketogenic diet
Diet composition shapes tissue function and disease risk by modulating nutrient availability, metabolic state, and cellular dynamics. In the gastrointestinal tract, obesogenic high-fat diets enhance intestinal stem cell activity and tumorigenesis. However, the impact of ketogenic diets (KD), which contain even higher lipid content but induce ketogenesis, remains poorly understood. This is particul...
Shay, J. E. S.
•
Chi, F.
•
Tzouanas, C. N.
•
Hoeve-Scott, J. T.
...•
Yilmaz, O. H.
biorxiv
Sat Jun 07 2025
Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis
Pancreatic cancer patients have the highest rates and most severe forms of cancer cachexia, yet cachexia etiologies remain largely elusive, leading to a lack of effective intervening therapies. PTHrP has been clinically implicated as a putative regulator of cachexia, with serum PTHrP levels correlating with increased weight loss in PDAC patients. Here we show that cachectic PDAC patients have high...
Bhalerao, N. U.
•
Ogoti, Y.
•
Peura, J.
•
Johnson, C.
...•
Pitarresi, J. R.
biorxiv
Sat Jun 07 2025
A multi-step immune-competent genetic mouse model reveals phenotypic plasticity in uveal melanoma
Uveal melanoma (UM) is a highly aggressive intraocular malignancy with limited therapeutic options for metastatic disease. Existing transgenic UM mouse models inadequately recapitulate human disease progression, while transplant models lack immune competence for studying the tumor immune microenvironment and therapeutic interventions. To address these limitations, we developed a genetically engine...
Xu, X.
•
Liu, X.
•
Dollar, J.
•
Liu, X.
...•
Karreth, F. A.
biorxiv
Sat Jun 07 2025
Integrative analysis of mRNA stability regulation uncovers a metastasis-suppressive program in breast cancer
Heterogeneity in cancer gene expression is typically linked to genetic and epigenetic alterations, yet post-transcriptional regulation likely influences these patterns as well. However, the quantitative contribution of post-transcriptional mechanisms to cancer transcriptome dynamics remains unclear. Here, we systematically measured mRNA dynamics across diverse breast cancer models, revealing that ...
Karner, H.
•
Mittmann, T. C.
•
Chen, V. W.
•
Borah, A. A.
...•
Goodarzi, H.